The role of SIOP as a platform for communication in the global response to childhood cancer.
Since the year 2000, there has been a 35% annual decrease in mortality among children under the age of five worldwide. The decrease is mainly attributed to the decrease in childhood epidemic infections, for example, due to vaccination programs. In the near future, this decrease will draw attention to paediatric non-communicable diseases (NCDs), and cancer is one of the most common. Access to care for children with cancer and survival rates have improved dramatically in high-income countries. However, it is important that a global perspective addresses problems in developing countries in particular. To meet this challenge, it is critical that emphasis is placed on demands such as access to care and drugs that are known to be effective, and which can be safely administered in resource-limited settings. Additionally, cancer registries and improved health care structures that include care for children with cancer, are paramount for further progress to increase awareness and the survival of children with cancer. The purpose of this paper is to describe current worldwide interventions to improve childhood cancer from the perspective of the International Society of Paediatric Oncology (SIOP). This global perspective will serve as an introduction to a series of papers from six SIOP continental branches, which will highlight the specific and/or common issues related to children with cancer worldwide. To strengthen the communication among and synergistic effects of various paediatric cancer stakeholders, SIOP could serve as a global platform for a proposed Global Paediatric Cancer Network through the interaction of its continental branches and partner collaborations.
University of Muenster, Paediatric Haematology and Oncology, Muenster, Germany.
Gabriele
G
Calaminus
Jillian R
JR
Birch
Rachel
R
Hollis
Benson
B
Pau
Mariana
M
Kruger
D002648:Child; D003142:Communication; D014943:Global Health; D006301:Health Services Needs and Demand; D006801:Humans; D007391:International Cooperation; D009369:Neoplasms; D012955:Societies, Medical
adapted protocols; clinical trials; communication platform; developing countries; epidemiology; essential medicines; paediatric haematology/oncology